Brief: Genor Biopharma Says On 2 Aug, Co Entered License Deal And Stock Purchase Deal With TRC 2004
05/08/2024 24:49
Aug 5 (Reuters) - Genor Biopharma Holdings Ltd
6998.HK :
* ON 2 AUGUST, CO ENTERED LICENSE AGREEMENT AND STOCK
PURCHASE
AGREEMENT WITH TRC 2004
* TO GRANT TRC 2004 EXCLUSIVE WORLDWIDE LICENSE TO DEVELOP,
USE,
MANUFACTURE, COMMERCIALIZE AND OTHERWISE EXPLOIT GB261
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman